Biotech RadarJobs updated

COMPANY

IMUNON

HQ: Lawrenceville, NJ source · imunon.com ↗ · Mid-Atlantic

Clinical Phase 3

Keywords: oncology ovarian cancer cancer vaccine immunology Fallopian Tube Cancer Primary Peritoneal Cancer Epithelial Ovarian Cancer Hepatocellular Carcinoma Breast Cancer Primary Peritoneal Carcinoma SARS CoV 2 Infection Colon Cancer Liver Metastasis Liver Neoplasms Painful Bone Metastases Breast Carcinoma Non-small Cell Lung Cancer Small Cell Lung Cancer Adenocarcinoma Prostate Cancer IMNN-001 IMNN-101 ThermoDox

Location: Lawrenceville, NJ · source · Oct 14, 2026

Profile checked Oct 10, 2026

$10.0MRaised (2 yrs)15Trials (company is sponsor)

Timeline

  1. Raise Private placement: $10M (up to, as announced), announced Jun 4, 2026. Source: SEC filing. source ↗
  2. Trial start 3: Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primar source ↗
  3. Trial start Phase 1/Phase 2: Study to Evaluate the Safety & Immunogenicity of IMNN-101 Administered in Healthy Adults Previously Vaccinated Against SARS-CoV-2 source ↗
  4. Trial start II: Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer source ↗
  5. Trial start Phase 1/Phase 2: Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2) source ↗
  6. Trial start Phase 2: Heat-Activated Target Therapy of Local-Regional Relapse in Breast Cancer Patients source ↗
  7. Trial start Phase 1: Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian Cancer source ↗
  8. Trial start Phase 3: Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC) source ↗
  9. Trial start 1: Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall source ↗
  10. Trial start Phase 2: MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases source ↗
  11. Trial start 2: Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC) source ↗
  12. Trial start 3: Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC) source ↗
  13. Trial start Phase 1: A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver source ↗
  14. Trial start Phase 1: Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancer source ↗
  15. Trial start Phase 2: Combination Chemotherapy With or Without Microwave Thermotherapy Before Surgery in Treating Women With Locally Advanced Breast Cancer source ↗
  16. Trial start Phase 2: Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Funding

Raised: $10.0M. Last 2 years.

Clinical trials (lead sponsor) 15

RecordTitlePhaseStatusStartPrimary completion
NCT05739981Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal CancerIIRecruitingFeb 10, 2023Jun 30, 2027 (estimated)
NCT06915025Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer3RecruitingJul 9, 2025Oct 31, 2032 (estimated)
NCT03393884Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)Phase 1/Phase 2Active, not recruitingSep 5, 2018Jul 25, 2024 (actual)
NCT06283459Study to Evaluate the Safety & Immunogenicity of IMNN-101 Administered in Healthy Adults Previously Vaccinated Against SARS-CoV-2Phase 1/Phase 2CompletedJun 4, 2024Mar 7, 2025 (actual)
NCT02480374Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian CancerPhase 1Completed2015-092017-05 (actual)
NCT02112656Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)Phase 3Completed2014-06Apr 27, 2020 (actual)
NCT00617981Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)3Completed2008-052013-01 (actual)
NCT01464593Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC)2Terminated2011-092013-05 (actual)
NCT02850419Heat-Activated Target Therapy of Local-Regional Relapse in Breast Cancer PatientsPhase 2Withdrawn2017-032019-12 (estimated)
NCT00441376A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the LiverPhase 1Completed2007-022008-10 (actual)
NCT01640847MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone MetastasesPhase 2Withdrawn2012-072013-06 (actual)
NCT00826085Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall1Completed2013-022015-12 (actual)
NCT00036985Combination Chemotherapy With or Without Microwave Thermotherapy Before Surgery in Treating Women With Locally Advanced Breast CancerPhase 2Unknown status (ClinicalTrials.gov)2001-08Not listed
NCT00036998Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast CancerPhase 2Unknown status (ClinicalTrials.gov)2001-08Not listed
NCT00061867Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate CancerPhase 1Completed2003-03Not listed

Raises and investors new

Form D raises come from the company’s own SEC filing (last 2 years).

Feedback